Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase I Study of Cryosurgery in Women With Highly Suspicious Breast Lesions

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
Phase I	Treatment	Completed	Any age	NCI	UCLA-9908076 NCI-G01-1964, NCT00020852

Trial Description

Purpose:

Cryosurgery kills cancer cells by freezing them. Cryosurgery followed by lumpectomy or mastectomy may be an effective treatment for breast lesions.

Phase I trial to study the effectiveness of cryosurgery in treating women who have breast lesions.

Eligibility:

• Any age
• No previous surgical biopsy
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will undergo cryosurgery. Within 3-21 days they will undergo surgery to remove either the lesion or the entire breast. Patients will be evaluated at 1 week and then once a month for 3 months.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Jonsson Comprehensive Cancer Center at UCLA

Helena Chang, MD, PhD, Principal investigator		Ph: 310-794-5640; 888-798-0719 Email: hchang@mednet.ucla.edu

Registry Information
Official Title		Evaluation of Freezing Tumors in the Treatment of Breast Cancer Safety Study - 1-Probe CRYOcare Surgical System for Breast Tumor Ablation
Trial Start Date		2001-05-03
Registered in ClinicalTrials.gov		NCT00020852
Date Submitted to PDQ		2001-05-08
Information Last Verified		2004-05-18
NCI Grant/Contract Number		P30-CA16042

Back to Top